This guideline covers endoscopy treatments for people aged 18 and over with Barrett’s oesophagus and high-grade dysplasia or intramucosal cancer. It offers advice on which types of endoscopy treatments should be offered and how these should be used. It aims to improve choice of treatment for adults with Barrett’s oesophagus and improve quality of life and survival for those who cannot have surgery.
This guideline includes recommendations on:
- endoscopic therapies
- endoscopic mucosal resection
- ablative therapies
- endoscopic mucosal resection with ablative therapies
- patient and carer support and information
Who is it for?
- Healthcare professionals
- Adults with Barrett’s oesophagus, their families and carers
Is this guideline up to date?
We checked this guideline in February 2014. We identified no major studies that will affect the recommendations in the next 3 to 5 years.
Next review: To be scheduled
Guideline development process
This guideline was previously called Barrett’s oesophagus: ablative therapy for the treatment of Barrett’s oesophagus.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.